The DOI matches its OpenAlex record; 252 of the 252 references it cites were found in a registry or an index.
Dopamine Receptor Signaling
Open accessAbstract
The D1-like (D1, D5) and D2-like (D2, D3, D4) classes of dopamine receptors each has shared signaling properties that contribute to the definition of the receptor class, although some differences among subtypes within a class have been identified. D1-like receptor signaling is mediated chiefly by the heterotrimeric G proteins Galphas and Galphaolf, which cause sequential activation of adenylate cyclase, cylic AMP-dependent protein kinase, and the protein phosphatase-1 inhibitor DARPP-32. The increased phosphorylation that results from the combined effects of activating cyclic AMP-dependent protein kinase and inhibiting protein phosphatase 1 regulates the activity of many receptors, enzymes, ion channels, and transcription factors. D1 or a novel D1-like receptor also signals via phospholipase C-dependent and cyclic AMP-independent mobilization of intracellular calcium. D2-like receptor signaling is mediated by the heterotrimeric G proteins Galphai and Galphao. These pertussis toxin-sensitive G proteins regulate some effectors, such as adenylate cyclase, via their Galpha subunits, but regulate many more effectors such as ion channels, phospholipases, protein kinases, and receptor tyrosine kinases as a result of the receptor-induced liberation of Gbetagamma subunits. In addition to interactions between dopamine receptors and G proteins, other protein:protein interactions such as receptor oligomerization or receptor interactions with scaffolding and signal-switching proteins are critical for regulation of dopamine receptor signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–252 of 252
Davila, V., Yan, Z., Craciun, L. C., Logothetis, D. E., & Sulzer, D. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05693.2003 · Cited by 65
Zhang, L., & Reith, M. E. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00646-2 · Cited by 64
Dopamine facilitates striatal EPSPs through an L-type Ca2+ conductance
Galarraga, E., Hernández‐López, S., Reyes, A., Barral, J. A., & Bargas, J. (1997) · Neuroreport · doi:10.1097/00001756-199707070-00019 · Cited by 64
Seabrook, G. R., Kemp, J. A., Freedman, S. B., et al. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14746.x · Cited by 64
Clifford, J. J., Tighe, O., Croke, D. T., Kinsella, A., Sibley, D. R., Drago, J., & Waddington, J. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00297-3 · Cited by 63
Activation of Type II Adenylate Cyclase by D2 and D4 but Not D3 Dopamine Receptors
Watts, V. J., & Neve, K. A. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.181 · Cited by 63
Self-citationSeabrook, G. R., Knowles, M. R., Brown, N. A., Myers, J., Sinclair, H., Patel, S., Freedman, S. B., & McAllister, G. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13138.x · Cited by 62
Sidhu, A. (1998) · Molecular Neurobiology · doi:10.1007/bf02740640 · Cited by 62
Signal transduction pathways modulated by the D2 subfamily of dopamine receptors
Huff, R. M. (1996) · Cellular Signalling · doi:10.1016/s0898-6568(96)00074-5 · Cited by 61
Lajiness, M. E., Chio, C. L., & Huff, R. M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39451-6 · Cited by 61
Felder, C. C., Albrecht, F. E., Campbell, T. G., Eisner, G. M., & José, P. A. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.264.6.f1032 · Cited by 60
Gomes, P., & Soares-da-Silva, P. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00318.2001 · Cited by 59
Kuzhikandathil, E. V., & Oxford, G. S. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01698.1999 · Cited by 58
Senogles, S. E. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.455 · Cited by 58
Watson, J. B., Coulter, P. M., Margulies, J. E., de Lecea, L., Danielson, P. E., Erlander, M. G., & Sutcliffe, J. G. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390113 · Cited by 57
Pacheco, M. A., & Jope, R. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020639.x · Cited by 57
McNamara, F. N., Clifford, J. J., Tighe, O., Kinsella, A., Drago, J., Croke, D. T., & Waddington, J. L. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300008 · Cited by 56
Regulation and functional characterization of a rat recombinant dopamine D3 receptor
Cox, B., Rosser, M. P., Kozlowski, M. R., Duwe, K., Neve, R. L., & Neve, K. A. (1995) · Synapse · doi:10.1002/syn.890210102 · Cited by 50
Self-citationLew, J. Y., García‐España, A., Lee, K. Y., Carr, K. D., Goldstein, M., Haycock, J. W., & Meller, E. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.202 · Cited by 49
Gross, R. A., Uhler, M. D., & Macdonald, R. L. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018268 · Cited by 49
Two different mechanisms of calcium spike modulation by dopamine
Paupardin‐Tritsch, D., Colombaioni, L., Déterre, P., & Gerschenfeld, H. M. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02522.1985 · Cited by 49
Mechanism of Gαi-mediated Inhibition of Type V Adenylyl Cyclase
DESSAUER, C. W., Chen‐Goodspeed, M., & Chen, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203962200 · Cited by 47
Ghahremani, M. H., Forget, C., & Albert, P. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1497-1506.2000 · Cited by 47
Kuzhikandathil, E. V., & Oxford, G. S. (2000) · The Journal of General Physiology · doi:10.1085/jgp.115.6.697 · Cited by 46
Zhen, X., Zhang, J., Johnson, G., & Friedman, E. (2001) · PubMed · Cited by 43
Liu, L., Shen, R., Kapatos, G., & Chiodo, L. A. (1994) · Synapse · doi:10.1002/syn.890170404 · Cited by 39
Weissman, J. T., Ma, J., Essex, A., Gao, Y., & Burstein, E. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207014 · Cited by 39
Yamaguchi, I., Harmon, S. K., Todd, R. D., & O’Malley, K. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16599 · Cited by 37
Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase
Leonard, S. K., Anderson, C. M., Lachowicz, J. E., Schulz, D. W., Kilts, C. D., & Mailman, R. B. (2003) · Synapse · doi:10.1002/syn.10272 · Cited by 36
Hyperactivity and dopamine D 1 receptor activation in mice lacking girk2 channels
Blednov, Y. A., Stoffel, M., Cooper, R., Wallace, D., Mane, N., & Harris, R. A. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0937-6 · Cited by 36
Senogles, S. E. (1994) · Endocrinology · doi:10.1210/endo.134.2.7507837 · Cited by 36
Svensson, E., Wikström, M. A., Hill, R. H., & Grillner, S. E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02466.x · Cited by 35
Nilsson, C. L., Hellstrand, M., Ekman, A., & Eriksson, E. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702025 · Cited by 34
Lin, C., Varma, M. G., Joubel, A., Madabushi, S., Lichtarge, O., & Barber, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212315200 · Cited by 33
Valenzuela, C. F., Kazlauskas, A., Brozowski, S. J., Weiner, J. L., DeMali, K. A., McDonald, B. J., Moss, S. J., Dunwiddie, T. V., & Harris, R. A. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10582-8 · Cited by 30
Requirement for DARPP‐32 in mediating effect of dopamine D2 receptor activation
Nishi, A., Snyder, G. L., Fienberg, A. A., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00724.x · Cited by 30
Adenylyl Cyclase Type II Domains Involved in Gβγ Stimulation
Weitmann, S., Schultz, G., & Kleuss, C. (2001) · Biochemistry · doi:10.1021/bi011176w · Cited by 30
Association of dopamine D3 receptors with actin-binding protein 280 (ABP-280)
Li, M., Li, C., Weingarten, P., Bunzow, J. R., Grandy, D. K., & Zhou, Q. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00932-7 · Cited by 29
Signaling Pathways Modulated by Dopamine Receptors
Huff, R. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2635-0_6 · Cited by 28
Marzo, V. D., & Piomelli, D. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08915.x · Cited by 28
van Tol-Steye, H., Lodder, J. C., Mansvelder, H. D., et al. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03739.1999 · Cited by 26
Nally, R. E., McNamara, F. N., Clifford, J. J., Kinsella, A., Tighe, O., Croke, D. T., Fienberg, A. A., Greengard, P., & Waddington, J. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300259 · Cited by 25
Dopamine modulates a voltage-gated calcium channel in rat olfactory receptor neurons
Okada, Y., Miyamoto, T., & Toda, K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02267-4 · Cited by 24
SH3 ligands in the dopamine D3 receptor
Oldenhof, J., Ray, A. P., Vickery, R., & Tol, H. H. M. V. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00157-7 · Cited by 20
D1/D2 Dopamine Receptor Interactions in Basal Ganglia Functions
Marshall, J. F., Ruskin, D. N., & LaHoste, G. J. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2635-0_7 · Cited by 19
Nickolls, S. A., & Strange, P. G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00040-6 · Cited by 18
Interactions of Dopamine Receptors with G Proteins
Robinson, S. W., & Caron, M. G. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2635-0_5 · Cited by 17
Structural Analysis of the Mammalian D2, D3 and D4 Dopamine Receptors
Neve, K. A., DuRand, C. J., & Teeter, M. M. (2003) · CRC Press eBooks · doi:10.1201/b15280-4 · Cited by 14
Self-citationShahedi, M., Laborde, K., Azimi, S., et al. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00374808 · Cited by 13
Nilsson, C. L., Hellstrand, M., Ekman, A., & Eriksson, E. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00020-x · Cited by 11
Differential phosphorylation at serine sites in glutamate receptor-1 within neonatal rat hippocampus
Li, A., Suzuki, M., Suzuki, S., Ikemoto, M. J., & Imamura, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00157-5 · Cited by 10
Structure of Mammalian D1 and D5 Dopamine Receptors and Their Function and Regulation in Cells
Demchyshyn, L. L., O’Dowd, B. F., & George, S. R. (2003) · CRC Press eBooks · doi:10.1201/b15280-3 · Cited by 5
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Modulation of Striatal Projection Systems by Dopamine
Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,718
The Neuroscience of Drug Reward and Addiction
Volkow, N. D., Michaelides, M., & Baler, R. (2019) · Physiological Reviews · doi:10.1152/physrev.00014.2018 · Cited by 863
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Metadata
- Authors
- Neve, K. A., Seamans, J. K., & Trantham‐Davidson, H.
- Venue
- Journal of Receptors and Signal Transduction
- Publisher
- Taylor & Francis
- Published
- 2004-01-01
- Volume
- 24
- Issue
- 3
- Pages
- 165-205
- ISSN
- 1079-9893 (ISSN-L)
- OpenAlex
- W2086880198
- Cited by
- 837
- References
- 252
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.